Caplin Point Laboratories Ltd (BOM:524742)
₹ 1420.8 1.3 (0.09%) Market Cap: 108.00 Bil Enterprise Value: 99.65 Bil PE Ratio: 23.66 PB Ratio: 4.66 GF Score: 98/100

Q2 2021 Caplin Point Laboratories Ltd Earnings Call Transcript

Nov 06, 2020 / 05:30AM GMT
Release Date Price: ₹486.05 (-2.46%)
Operator

Ladies and gentlemen, good day, and welcome to the Caplin Point Lab's Conference Call for Q2 FY '21 Earnings Conference hosted by Centrum Broking Limited. (Operator Instructions) I now hand the conference over to Ms. Cyndrella Carvalho, from Centrum Broking. Thank you, and over to you, ma'am.

Cyndrella Carvalho
Centrum Broking Limited, Research Division - Analyst of Pharmaceuticals

Thanks, Lynda. Good morning, everyone. On behalf of Centrum Broking, I Cyndrella Carvalho thank the management of Caplin Point Laboratories Limited for giving us this opportunity to host the Q2 FY '21 earnings con call.

Today from the management team of Caplin Point Laboratories, we have with us the Chairman sir, Mr. C.C. Paarthipan; Chief Operating Officer, Mr. Vivek Partheeban; Managing Director, Dr. Sridhar Ganesan; Chief Financial Officer, Mr. D. Muralidharan; Deputy Chief Financial Officer, Mr. M. Sathya Narayanan; Company Secretary, Mr. Vinod Kumar.

At the outset, I would like to thank the management for this opportunity again and congratulate on delivering

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot